HOME
[Update] RECALL - Similac Infant Formulas
[FDA MedWatch] Symptoms of Gastrointestinal Discomfort
악업신문 편집국 기자
news@yakup.com 
기자가 쓴 기사 더보기
기자가 쓴 기사 더보기
입력 2010.09.25 10:33
수정 2010.09.26 02:24
(편집자 주 - 2010년 9월 24일 미국 FDA에서 보내온 씨밀락 (Similac) 리콜 관련 업데이트 입니다.)
Similac Powder Infant Formulas: Recall
[UPDATED 09/24/2010] The voluntary recall affects milk- and soy-based formulas distributed in the United States, Puerto Rico, Guam, and some Caribbean nations.
At least 12 of the recalled products were provided to families through the federal government’s Women, Infants, and Children (WIC) health and nutrition program.
FDA is reassuring caregivers and families whose babies may have consumed recalled products that drinking the formula will not cause long-term health problems.
FDA has created a searchable database to find lot numbers of affected products. The Consumer Update offers a printer-friendly PDF which can be shared with consumers and patients.
Similac Powder Infant Formulas: Recall
[UPDATED 09/24/2010] The voluntary recall affects milk- and soy-based formulas distributed in the United States, Puerto Rico, Guam, and some Caribbean nations.
At least 12 of the recalled products were provided to families through the federal government’s Women, Infants, and Children (WIC) health and nutrition program.
FDA is reassuring caregivers and families whose babies may have consumed recalled products that drinking the formula will not cause long-term health problems.
FDA has created a searchable database to find lot numbers of affected products. The Consumer Update offers a printer-friendly PDF which can be shared with consumers and patients.
오늘의 헤드라인
전체댓글 0개
등록된 댓글이 없습니다.
| 인기기사 | 더보기 + |
-
1 베일 벗은 에이비엘바이오 비장의 카드㊤ siRNA와 그랩바디-B -
2 메지온 "희귀소아질환 '신속심사바우처'부활,미국 대통령 최종 승인" -
3 파킨슨병 권위자 한자리에…“이제는 임상에서 답해야 할 때” -
4 보로노이,비소세포폐암 환자 'VRN110755' 임상1상 IND 호주 승인 -
5 "염증·혈관·섬유화·세포치료" 신장병 극복 K-바이오 4색 전략 -
6 베일 벗은 에이비엘바이오 비장의 카드㊦ siRNA가 ‘꿈의 기술’인 이유 -
7 "파킨슨병 정복, 도파민 보충 넘어 질환 조절 패러다임 바뀐다" -
8 아미코젠, 인도 대리점 Aruni 통해 IEX 레진 첫 상업용 수주 확보 -
9 케어젠, 신규 전달 기술 '히알루로니다제 펩타이드' 최초 공개 -
10 "국내 최초 AI 기반 PK·PD 모델링 특화 기업 'APLUS 시뮬레이션' 등장"
| 인터뷰 | 더보기 + |
| PEOPLE | 더보기 + |
| 컬쳐/클래시그널 | 더보기 + |
|
서울시 서초구 서초대로 115 정다운빌딩 4층 TEL : 02-3270-0114 FAX : 02-3270-0189 E-mail : webmaster@yakup.com |
발행일 : 1954. 03. 29 등록일 : 2016. 05. 02 대표이사 : 함태원 발행 · 편집인 : 함태원 등록번호 : 서울,아04071 |
사업자등록번호 : 106-81-10940 통신사업자신고번호 : 제2022-서울서초-2586호 청소년보호책임자 : 이종운
Copyright © Yakup.com All rights reserved.
|
[Update] RECALL - Similac Infant Formulas
[FDA MedWatch] Symptoms of Gastrointestinal Discomfort
- 악업신문 편집국 기자 news@yakup.com
- 입력 2010.09.25 10:33 수정 2010.09.26 02:24
(편집자 주 - 2010년 9월 24일 미국 FDA에서 보내온 씨밀락 (Similac) 리콜 관련 업데이트 입니다.)
Similac Powder Infant Formulas: Recall
[UPDATED 09/24/2010] The voluntary recall affects milk- and soy-based formulas distributed in the United States, Puerto Rico, Guam, and some Caribbean nations.
At least 12 of the recalled products were provided to families through the federal government’s Women, Infants, and Children (WIC) health and nutrition program.
FDA is reassuring caregivers and families whose babies may have consumed recalled products that drinking the formula will not cause long-term health problems.
FDA has created a searchable database to find lot numbers of affected products. The Consumer Update offers a printer-friendly PDF which can be shared with consumers and patients.
Similac Powder Infant Formulas: Recall
[UPDATED 09/24/2010] The voluntary recall affects milk- and soy-based formulas distributed in the United States, Puerto Rico, Guam, and some Caribbean nations.
At least 12 of the recalled products were provided to families through the federal government’s Women, Infants, and Children (WIC) health and nutrition program.
FDA is reassuring caregivers and families whose babies may have consumed recalled products that drinking the formula will not cause long-term health problems.
FDA has created a searchable database to find lot numbers of affected products. The Consumer Update offers a printer-friendly PDF which can be shared with consumers and patients.
Copyright © Yakup.com All rights reserved.
약업신문 의 모든 컨텐츠(기사)는 저작권법의 보호를 받습니다.
무단 전재·복사·배포 등을 금지합니다.
무단 전재·복사·배포 등을 금지합니다.